A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol by David A. Palma, Meredith E. Giuliani, Rohann J. M. Correa, Famke L. Schneiders, Stephen Harrow, Matthias Guckenberger, Tina Zhang, Houda Bahig, Sashendra Senthi, Peter Chung, Robert Olson, Michael Lock, Srinivas Raman, Glenn S. Bauman, Benjamin H. Lok, Joanna M. Laba, Rachel M. Glicksman, Timothy K. Nguyen, Pencilla Lang, Joelle Helou, Christopher D. Goodman, Lucas C. Mendez, Peter S. N. van Rossum, Andrew Warner, Stewart Gaede, Alison L. Allan

Get full text